Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

iASPP inhibition: increased options in targeting the p53 family for cancer therapy.

iASPP inhibition: increased options in targeting the p53 family for cancer therapy. Cancer Res. 2008 Jul 01; 68(13):4959-62.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.